US9637489B2 - Immune system modulators - Google Patents

Immune system modulators Download PDF

Info

Publication number
US9637489B2
US9637489B2 US14/845,603 US201514845603A US9637489B2 US 9637489 B2 US9637489 B2 US 9637489B2 US 201514845603 A US201514845603 A US 201514845603A US 9637489 B2 US9637489 B2 US 9637489B2
Authority
US
United States
Prior art keywords
nr
alkyl
heterocycle
ch
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US14/845,603
Other versions
US20160074403A1 (en
Inventor
Grayson B. Lipford
Charles M. Zepp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janus Biotherapeutics Inc
Original Assignee
Janus Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201161491965P priority Critical
Priority to PCT/US2012/040417 priority patent/WO2012167046A1/en
Priority to US14/179,069 priority patent/US9126996B2/en
Priority to US201414122473A priority
Application filed by Janus Biotherapeutics Inc filed Critical Janus Biotherapeutics Inc
Priority to US14/845,603 priority patent/US9637489B2/en
Assigned to JANUS BIOTHERAPEUTICS, INC. reassignment JANUS BIOTHERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LIPFORD, GRAYSON B, ZEPP, CHARLES M
Publication of US20160074403A1 publication Critical patent/US20160074403A1/en
Application granted granted Critical
Publication of US9637489B2 publication Critical patent/US9637489B2/en
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links